3King RJB,Whitehead M. Assessment ofthe potency of orally administered progestins in womenl-J]. Fertil Steril, 1986,46 :1062-1066. 被引量：1
4Katz Z, Lancet M, Scomik J, Chemke J, et al. Teratogenicity of progestogins given during the first trimester of pregnancy[J]. Obstet Gynecol 1985,65 ;775-780. 被引量：1
6Walch K Hefler LNagele F. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS) . A double-blind, prospectively randomized, placebc/-controlled, parallel group trial [J]. J Matern Fetal Neonatal Med, 2005,18 .. 265-269. 被引量：1
7Queisser-Luft A. Dydrogesterone use during pregnancy: overview of birth defects reported since 1977[J]. Early Hum Dev, 2009,85:375-377. 被引量：1
9Azziz R,Woods KS,Reyna R,et al.The prevalence and features of the polycystie ovary syndrome in an unseleeted population[J].J Clin Endocrinol Metab, 2004,89 (6) : 2745 - 2749. 被引量：1
10Moreira S,Soares E,Tomaz G,et al.Polycystic ovary syn- drome : a psychosocial approach[J].Acta Med Port, 2010,23 (2) : 237-242. 被引量：1
